Singapore Healthcare Market Forecast to 2022-Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit The report titled “Singapore Healthcare Market Forecast to 2022 – by Type of Clinics (Medical and Dental), by Hospitals (Private, Public and Not-for-Profit), by Prescription and OTC Drugs, by type of Medical Devices (Consumables, Diagnostic Imaging, Patient Aids, Orthopedics & Prosthetics, Dental Products, and Others)” provides information on market size for Singapore hospital, pharmaceutical, pharmacy retail, clinics, Contract Research Organization and medical devices. The report covers aspects such as hospital market segment (by public, private & not-for-profit hospitals, by Inpatient & Outpatient and by Acute, Community & Psychiatry Hospitals), pharmaceutical market segment (by Prescription & OTC Drugs, by Patented & Generic Drugs), pharmacy retail market segment (by drugs & private-label goods and by region), CRO market segmentation (by Therapeutic Class & by Clinical Trial Phase) and medical device market segment (by type of medical device, and by end-user), competitive landscape of major players in the Singapore clinics market, hospital market, pharmaceutical market, pharmacy retail market, clinical laboratory market, CRO market and medical devices market and covering competitive landscape of major healthcare institutions including Singapore Medical group, Q&M Dental Group, Singapore General Hospital, Ferrer Park, Changi General Hospital, GSK, Singapore, Beacon pharmaceuticals, Guardian Pharmacy, Unity Pharmacy, Singapore Clinical Research Institute, QT Vascular, Biosensors International, National Healthcare Group Diagnostics, Innovative Diagnostics, and Radlink. The report concludes with market projections for future and analyst recommendations highlighting the major opportunities and cautions. Singapore Healthcare Market Overview Singapore has one of the best health infrastructures in the world. The population is aging and medical tourism will drive the demand for healthcare services in Singapore in the near future. Most of the expensive tertiary care services are provided by public hospitals at affordable rates. This is supported by the implementation of MediShield Life which is the National Health Insurance Scheme. Primary healthcare services are mostly provided by private sector practitioners and some by government polyclinics operating under MOH. Public hospitals and specialty centers engage in clinical research. Market Segmentation Singapore Hospital Market Singapore hospital’s market increased at a declining rate during 2012-2017. Macro trends positively affecting the hospital market include the ageing population, rising chronic disease prevalence, escalating healthcare needs and increasing complexity of care needs. Revenue from outpatients has accounted for the major share in the Singapore hospital market in 2017 followed by revenue generated from inpatient services. This was majorly due to a shift in focus towards preventive healthcare services which augmented the revenues from outpatient services. Acute hospitals have accounted for a majority share in the number of hospitals and the largest proportion of beds in 2017 followed by Community and psychiatric hospitals. Singapore Clinics Market Singapore clinics market increased at a positive CAGR during the review period. The market is at a growing stage with major clinic groups undertaking inorganic methods of expansion and widening their service portfolio. Medical clinics have accounted for the largest share in the overall revenue generated by clinics in Singapore in 2017. This is majorly driven by the organic and inorganic expansion of large players and the adoption of the asset-light model. Other major types of clinics include dental clinics. The central region of Singapore has accounted for the largest number of clinics in Singapore in 2017 driven by high population, and greater connectivity with other parts of Singapore. The north region has registered a robust concentration of the number of clinics in Singapore in 2017. Within this region, Woodlands and Yishun have the most number of clinics offering dental and family medicine. This is followed by the east region, west region, and south region. Singapore Pharmaceutical Market Singapore Pharmaceutical market can be characterized by the presence of best-in-class infrastructure, integrated and advanced hubs for pharmaceutical manufacturing and research and access to regional markets and skilled workforce. Singapore Pharmaceutical market has registered an increase in the revenue at a positive CAGR during 2012-2017. Prescription drugs have accounted for the largest share in the revenue in the Singapore pharmaceutical market in 2017 driven by new brands, high prices for existing drugs and fewer patent expiries. OTC drugs have accounted for the remaining share of the revenue owing to the rise in the trend of self-medication in Singapore. Patented drugs have accounted for the largest share in the revenue in the Singapore prescription drugs market in 2017. Generic drugs have accounted for the remaining share of the revenue. Singapore Pharmacy Retail Market Singapore pharmacy retail market revenue has escalated at a positive CAGR during 2012-2017. Private Label Goods have registered the largest share in the revenue share in Singapore pharmacy retail market 2017. Drugs have accounted for the remaining share in 2017. The sale of prescription drugs in Singapore is not as high as the doctor is allowed to sell those drugs at cheaper costs. Central Region has accounted for the largest number of pharmacies in Singapore in 2017 due to the presence of a large number of hospitals and clinics and supported by a high population. This is followed by north, east, west and south Singapore. Singapore Medical Device Market Singapore Medical device market is in the growing stage with a rise in the number of foreign players. Medical Consumables have accounted for the largest share in the revenue generated by the medical device market in Singapore in 2017. This is followed by diagnostic imaging products, patient aids, orthopedic & prosthetics, dental products. Others include Point of Care Testing devices, radiation oncology devices, therapy system, and testing and measurement systems. Ministry of Health which controls most of the hospitals and a significant proportion of the clinics in Singapore has accounted for the largest share in the revenue generated by medical devices in Singapore in 2017. Other healthcare institutions such as private hospitals and clinical laboratories have accounted for the remaining share. Key Topics Covered in the Report:- Singapore Clinics, Hospitals, Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO Market Size, 2012-2017 Singapore Hospitals Market Segmentation (by Public, Private Hospital & Not-for-Profit Hospital, by Inpatient & Outpatient, by Acute, Community & Psychiatry Hospitals) Singapore Clinics Market Segmentation (By Type Of Clinic And By Region) Singapore Medical Device Market Segmentation (By Type Of Medical Device, And By End User) Singapore Pharmaceutical Market Segmentation (by Prescription & OTC Drugs, by Patented & Generic Drugs) Singapore Pharmacy Retail Market Segmentation (by Drugs & Private Label Goods and By Region) Singapore Clinics, Hospitals, Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO Market Competitive Landscape Singapore Clinics, Hospitals, Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO Market Future Outlook and Projections, 2018-2022 Analyst Recommendations For More Information about the publication, refer to below link:- https://www.kenresearch.com/healthcare/general-healthcare/singapore-healthcare-market/154981-91.html Related Reports by Ken Research:- https://www.kenresearch.com/healthcare/general-healthcare/saudi-arabia-healthcare-market-research-report/1106-91.html https://www.kenresearch.com/healthcare/general-healthcare/uae-healthcare-market-report/37505-91.html https://www.kenresearch.com/healthcare/general-healthcare/qatar-healthcare-market-report/99730-91.html Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Post Views: 5 Tags: Clinics Future Trends Singapore, Clinics Market Singapore, Contract Research Organization (CRO) Market Singapore, Diabetes Prevalence Singapore, Healthcare Spending Singapore, Hospital Market Future Trends Singapore, Hospital Market Singapore, Indonesia Healthcare Singapore, Major Companies Medical Devices Market Singapore, Medical Devices Market Singapore, Number of Clinical Laboratories Singapore, Number of Clinics Singapore, Number of Hospitals Singapore, Number of Pharmacies Singapore, Pharmaceutical Market Singapore, Pharmacy Retail Market Singapore, Singapore Pharmaceutical Future, Type of Clinical Laboratory Singapore, Type of Medical Devices Singapore, Value Chain Pharmaceutical Market Singapore